Market Overview

J.P. Morgan Reiterates Neutral Rating, $41 PT on Walgreen Company

Related WAG
Morgan Stanley Thinks CVS Surcharge May Replace Lost Tobacco Revenue
Sears, Walgreen And Others Insiders Have Been Buying
Apple Easily Beats in Fiscal Fourth Quarter (Fox Business)

In a report published Monday, J.P. Morgan & Co. reiterated its Neutral rating and $41.00 price target on Walgreen Company (NYSE: WAG).

J.P. Morgan noted, “This morning WAG reported fiscal 1Q13 results. Adjusted EPS was $0.58, although adding back a $0.10 EPS swing related to a change in accounting for Alliance Boots equity income (moving from a 1-month reporting lag to a 1-quarter lag), adjusted EPS would have been $0.68. This compares to our $0.73 estimate and Bloomberg consensus of $0.70. We maintain our Neutral rating on the WAG shares. While the ESRX agreement removed an overhang and comps will get easier in CY13, we remain cautious based on the risks around script recapture, reimbursement pressure (especially as the generics tailwind lessens over the next several quarters) and macro risk in Europe potentially impacting Alliance Boots.”

Walgreen Company closed on Friday at $37.55.

Latest Ratings for WAG

DateFirmActionFromTo
Oct 2014Deutsche BankMaintainsBuy
Oct 2014JP MorganMaintainsOverweight
Oct 2014FBR CapitalMaintainsMarket Perform

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: J.P. Morgan & Co.Analyst Color Reiteration Analyst Ratings

 

Related Articles (WAG)

Around the Web, We're Loving...

Get Benzinga's Newsletters